top of page

Healthcare M&A Review Q2 2024

A review of mergers & acquisitions, private equity and venture capital activity across the UK healthcare sector in Q2 of 2024.

We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q2 of 2024.

Our report, which can be downloaded below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market.

Q2 2024 Healthcare M&A Review Summary

Deal volumes

  • Deal activity across the healthcare sector remained robust in Q2 of 2024, but still lower than the peaks seen in 2021/2022

  • There is undoubtedly now an uptick in market activity, with deal volumes expected to increase in the second half of the year as market confidence grows

  • The general election does not appear to be impacting M&A activity in the healthcare market, but potential changes to capital gains tax represent a risk

A chart showing the number of deals each month.

Sub-sector activity

  • The quarter saw a number of significant elderly care deals, with groups such as Danforth and Hartford Care taking on investment from private equity and infrastructure investors to support expansion

  • Strong digital health activity has been primarily focused on social care software and digitisation of the sector

  • Community-based and tech-enabled clinical services, as well as niche medical equipment specialists, also remain hot spots in terms of deal activity

A chart slowing the split of deals between sub-sectors within the healthcare sector.

Private equity involvement

  • Private equity activity remained strong during the quarter despite a limited number of suitable investment opportunities coming to market

  • The period saw new platform investments for Ethos (Bray Group), Inspirit Capital (Wilmington Healthcare), Bay Tree (ABL Health), Omni Partners (Compass CHC) and August (Impact Futures) amongst others


bottom of page